SALa ELISA kit (Human)

SKU: CEB892Hu

Size: 96Tests

# of Times Cited in literature: 15

Prepare Time: 2-7 days(please inquire for mutiple units)

Target Name: SALa

Target Full Name: Salusin Alpha

Alternative Names: -

Target Species: Human

Uniprot: Q8N2E6

Gene ID: 27433

Featured Series: CE kit

Featured Series Function: Detects small molecule

Specificity: Reactive with Human SALa / Salusin Alpha

Method: Colormetric

Detection principle: Competitive Inhibition

Detection range: 2.47-200pg/mL

Sensitivity: 0.93pg/mL

Assay Time: 2h

Sample Size: 50uL

Recommended/Predicted Sample Types: Serum, Plasma and other Biological Fluids

Assay Precision: Intra-Assay: CV<10%, Inter-Assay: CV<12%

Reproducibility test menthod: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Salusin Alpha (SALa) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Salusin Alpha (SALa) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100

Storage: 4°C for 1 month/ -20°C for long-term(One year within shelf life)

Shelf-life: 12 months

Specificity: This assay has high sensitivity and excellent specificity for detection of Salusin Alpha (SALa). No significant cross-reactivity or interference between Salusin Alpha (SALa) and analogues was observed.

Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary: 1. Prepare all reagents, samples and standards; 2. Add 50µL standard or sample to each well. And then add 50µL prepared Detection Reagent A immediately. Shake and mix. Incubate 1 hour at 37°C; 3. Aspirate and wash 3 times; 4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C; 5. Aspirate and wash 5 times; 6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C; 7. Add 50µL Stop Solution. Read at 450 nm immediately.

Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Salusin Alpha (SALa) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Salusin Alpha (SALa) and unlabeled Salusin Alpha (SALa) (Standards or samples) with the pre-coated antibody specific to Salusin Alpha (SALa). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Salusin Alpha (SALa) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Salusin Alpha (SALa) in the sample.

Research Area: Infection immunity;Endocrinology;Cardiovascular biology;Neuro science;

References Citing This Product: The bioactive peptides salusins and apelin–36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass

Presence of adropin, nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows

Association of low maternal levels of salusins with gestational diabetes mellitus and with small-for-gestational-age fetuses.

Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome

Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus

Brain, Liver, and Serum Salusin-alpha and-beta Alterations in Sprague-Dawley Rats with or Without Metabolic Syndrome

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?

Serum salusin-α and salusin-β levels in patients with psoriasis

Serum salusins levels are increased and correlated positively with cyst size in ovarian endometrioma

Increased level of Plasma Salusin-α and Salusin-β in patients with Multiple Sclerosis

Salusin-α levels are negatively correlated with diastolic blood pressure in children with obesity

Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis

Targeted Delivery of Salusin©\¦Á into Rabbit Carotid Arterial Endothelium Using SonoVue